Table 1:
Indiv. Used | ||||||
---|---|---|---|---|---|---|
Kit | Analysis | Strain | Reported in | # in Pool | Female | Male |
| ||||||
Arbor | ||||||
Pilot Study | Oxt +/+ | Appendix | 2 | 3 | ||
Oxt −/− | 2 | 4 | ||||
Pools for Inter- and Intra-assay CVs | Oxt +/+ | 2.32 | 6 | |||
| ||||||
Individual Samples - Unextracted | Oxt +/+ | 3.1–3.3 | 11 | 7 | ||
Oxt −/− | 3.1 | 12 | 4 | |||
Individual Samples - Extracted | Oxt +/+ | 3.1–3.3 | 9 | 9 | ||
Oxt −/− | 3.1 | 12 | 4 | |||
| ||||||
UE Parallelism (1) & Spike Recovery | C57BL/6J | 8 | ||||
UE Parallelism (2) | C57BL/6J | 10 | ||||
SPE Parallelism & Spike Recovery | Oxt +/+ | 3.4 | 6 | |||
KO Parallelism, Spike Recovery & Extraction Efficiency | Oxt −/− | 9 | ||||
| ||||||
All | Kit Comparison Pools | Oxt +/+ | 3.5.1 | ~50 | ||
Oxt −/− | ~50 | |||||
| ||||||
Enzo | Individual Samples | Oxt +/+ | 3.5.2 | 1 | 9 | |
Oxt −/− | 1 | 8 | ||||
| ||||||
Cayman | Individual Samples (Subset of Enzo Individuals) | Oxt +/+ | 3.5.3 | 1 | 4 | |
Oxt −/− | 1 | 4 |